Showing 1851-1860 of 8080 results for "".
Origins of AD: Recent Advances
https://practicaldermatology.com/issues/april-2025/origins-of-ad-recent-advances/35586/This paper reviews a study by Yadev et al. and further investigates the role of transient receptor potential ankyrin 1 (TRPA1) in the pathogenesis of atopic dermatitis (AD).New Hope for Patients with Onychomycosis
https://practicaldermatology.com/issues/practicaldermatology-com-march-2025/new-hope-for-patients-with-onychomycosis/33161/Onychomycosis, a non-self-healing fungal infection of the toenails or fingernails, is a common infection accounting for 20% of all nail diseases in adults, affecting 5% of the worldwide population.What's New in Atopic Dermatitis?
https://reachmd.com/programs/practical-dermatology/whats-new-in-atopic-dermatitis/33014/Emma Guttman, MD, PhD, professor and chair of dermatology at Mount Sinai, talks about the latest developments in treatments and therapies for atopic dermatitis.In-Depth From the Science of Skincare Summit
https://practicaldermatology.com/issues/january-february-2025/in-depth-from-the-science-of-skincare-summit/32979/The 2024 Science of Skincare Summit this past November again positioned itself as a pivotal event in the dermatology field, offering groundbreaking insights into the intersection of innovation, consumer trends, and evidence-based skincare. Take a closer look at some of the research.Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
https://practicaldermatology.com/series/dermwire-tv/analysis-evaluates-risks-of-cardiovascular-events-among-biologics-for-psoriatic-diseases/32412/In this week's DermwireTV, a new analysis evaluates the risks of major adverse cardiovascular events among patients treated with biologics for psoriatic diseases; a phase 3 clinical trial examines the use of nemolizumab in adults with prurigo nodularis; and the president of Journey Medical discussesFDA Approves Botox for Vertical Platysma Bands
https://practicaldermatology.com/series/dermwire-tv/fda-approves-botox-vertical-platysma-bands/29127/In this week's DermwireTV, Botox is approved for its fourth aesthetic indication in the US; the FDA clears a new laser for the long-term treatment of patients with acne vulgaris; and the Chief Scientific Officer of Leo Pharma talks about treatment options for chronic hand eczema.Active Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.To Sell or Not to Sell to Private Equity?
https://practicaldermatology.com/conferences/scale-2023/to-sell-or-not-to-sell-to-private-equity/20195/Joel L. Cohen, MD, and George Hruza MD, discuss the pros and cons of selling to private equity. Pros include back-office support and better pricing on technology and supplies, while cons can include giving up autonomy.What’s the Latest in Hair Management?
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/whats-the-latest-in-hair-management/20113/Chytra Anand, MD, Neil Sadick, MD, and Brooke Jackson, MD offer insights on the best approaches to managing hair from global clinical experience to strategies for understanding the needs of each individual patient, they share tips to improve clinical outcomes.SEO basics- Google ranking factors that you can’t afford to ignore
https://practicaldermatology.com/topics/practice-management/seo-basics-google-ranking-factors-that-you-cant-afford-to-ignore/20086/Are you overwhelmed by the abundance of SEO tips and Google ranking factors? At a loss for where to focus your efforts? Check out this video from Ekwa Marketing (www.ekwa.com) for the shortlist of what really matters in dermatology marketing.